DiaMedica gains Health Canada approval for Phase II preeclampsia trial
Recruitment is expected to begin later this year, with plans for geographic expansion into the UK and the US.
Clinical Trials
Seqster unveils 1-Click DataLake for clinical trials
MIRA Pharmaceuticals completes dosing in Ketamir-2 Phase I trial
HUTCHMED begins Phase I/IIa trial of HMPL-A580 for solid tumours
Syntis Bio begins patient dosing in Phase I trial of SYNT-101 for obesity
Kyowa Kirin discontinues ongoing trials of rocatinlimab
Faron and City of Hope to develop Phase II trial of bexmarilimab for r/r MDS
Roche’s Phase III trial of fenebrutinib in RMS meets primary endpoint
